The study was small — just 48 adults — and lasted just over two months, so it’s not the final word. But the results add to evidence that GLP-1 drugs like Ozempic might help with cravings for things ...
Excess body weight—including overweight and obesity—is a significant risk factor for cancer. Research from the American Cancer Society estimates that it contributes to approximately 5 percent of ...
Mitolyn is a novel weight loss supplement that has been the subject of much discussion recently online. According to the ...
Cardiovascular diseases claim more lives in the U.S. than all forms of cancer and accidental deaths combined, according to ...
When it comes to achieving healthy body weight, some men might look to what’s average and use that as their goal. For ...
Recent reports reveal heart disease is the leading cause of death in the U.S., many of whom are younger than 45. Here's what ...
Scientists mapped fat tissue differences in obese individuals, uncovering cell changes linked to metabolic disease risk and ...
The fashion industry is notorious for its exclusionary preferences for certain body types. The Kansas City curve fashion ...
For all the buzz surrounding weight loss medications like semaglutide and tirzepatide, these drugs aren’t perfect. They come with a risk of side effects like nausea and diarrhea ...
Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary ...
Dr. Christina Funk of MetabolicCareNP has a diagnosis for the American medical system. Patients are frustrated with insurance hurdles and provider visits that last only a few minutes. Healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback